Type 2 diabetes is a growing problem for the developed and developing countries and it is a burden on healthcare systems as well as individuals. Nutraceuticals, Glycemic Health and Type 2 Diabetes primarily focuses on the nutraceuticals that assist in preventing and managing prediabetes and type 2 diabetes. The book gives an overview of glycemic health and highlights the use of novel and upcoming nutraceutical ingredients such as bioactive peptides, traditional herbs from India and Mexico, resistant starches, cinnamon, chromium III and others. After the successful commercial application of bioactive peptides as nutraceutical ingredients in the management of blood pressure, companies are now focusing on peptides for the prevention and management of type 2 diabetes. Resistant starches in the clinical studies have demonstrated to reduce the glycemic and insulin response and increasing insulin sensitivity. These and other nutraceuticals that are supported by scientific and clinical studies are highlighted. The editors and contributors are experts in their respective fields and are largely from the university, industry and government. Nutraceuticals, Glycemic Health and Type 2 Diabetes will be useful as a standard reference book for all those concerned with the role of nutraceuticals and glycemia in the prevention and control of type 2 diabetes.

Vijiai K. Pasupuleti, Ph.D. is founder of SAI International (Geneva, IL), a firm that engages in research, consulting and marketing for nutraceutical, pharmaceutical and biotechnology companies. At present Dr. Pasupuleti is actively involved in the nutraceuticals especially related to diabetes and has been managing his type 2 diabetes simply by using nutraceuticals combined with exercise and without any medication for more than 6 years. James W. Anderson, M.D. is Professor of Internal Medicine and Director, Metabolic Research Group, University of Kentucky College of Medicine, Lexington, KY and Professor of Clinical Nutrition, University of Kentucky. Previously, for thirty years Dr. Anderson was Chief, Endocrine-Metabolic Section, VA Medical Center, Lexington, Kentucky.